
ATTO vs DNA
$ATTO vs $DNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ATTO vs DNA: the quick read
- ·ATTO is the larger company by market cap ($673M vs $572M).
- ·DNA has been more active on our scanner (172 vs 50 alerts in 30 days).
- ·ATTO has the smaller float (43.3M vs 65.6M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·DNA draws far more of our scanner's attention, 172 unusual-volume alerts in 30 days against 50, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 18% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
Objective differences only. Not investment advice.
Watching ATTO or DNA? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ATTO and DNA on TheDesperateTrader.
- Is ATTO or DNA the better stock?
- "Better" depends on your goal, and these two are not alike. ATTO is the larger company by market cap ($673M vs $572M). DNA has been more active on our scanner (172 vs 50 alerts in 30 days). ATTO has the smaller float (43.3M vs 65.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ATTO and DNA?
- The differences that matter: they are not in the same business - ATTO is biological products, (no diagnostic substances) and DNA is biological products, (no diagnostic substances); they are similar in size ($673M vs $572M); they trade at very different share prices ($14.74 vs $8.57); ATTO sits at 12% of its 52-week range against 25% for DNA; our scanner flagged ATTO 50 times in the last 30 days against 172 for DNA. Everything above is measured from the latest completed session and SEC filings.
- Which of ATTO and DNA is more active right now?
- Right now ATTO is at about 0.5x its normal volume and DNA is at about 1.1x, so DNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ATTO or DNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ATTO and DNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.